Spectrum Pharmaceuticals, Inc. (SPPI): Price and Financial Metrics

Spectrum Pharmaceuticals, Inc. (SPPI): $1.07

-0.03 (-2.73%)

POWR Rating

Component Grades








Add SPPI to Watchlist
Sign Up

Industry: Biotech




#156 of 383

in industry

SPPI Price/Volume Stats

Current price $1.07 52-week high $1.57
Prev. close $1.10 52-week low $0.32
Day low $1.06 Volume 887,100
Day high $1.12 Avg. volume 2,211,424
50-day MA $0.92 Dividend yield N/A
200-day MA $0.74 Market Cap 219.63M

SPPI Stock Price Chart Interactive Chart >


  • SPPI scores best on the Sentiment dimension, with a Sentiment rank ahead of 94.12% of US stocks.
  • SPPI's strongest trending metric is Quality; it's been moving down over the last 105 days.
  • SPPI's current lowest rank is in the Stability metric (where it is better than 4.92% of US stocks).

SPPI Stock Summary

  • With a price/sales ratio of 9.09, SPECTRUM PHARMACEUTICALS INC has a higher such ratio than 88.31% of stocks in our set.
  • Revenue growth over the past 12 months for SPECTRUM PHARMACEUTICALS INC comes in at 154.39%, a number that bests 95.8% of the US stocks we're tracking.
  • In terms of volatility of its share price, SPPI is more volatile than 90.97% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to SPECTRUM PHARMACEUTICALS INC, a group of peers worth examining would be TVTX, SJ, PGEN, HCWB, and KLIC.
  • SPPI's SEC filings can be seen here. And to visit SPECTRUM PHARMACEUTICALS INC's official web site, go to www.sppirx.com.

SPPI Valuation Summary

  • In comparison to the median Healthcare stock, SPPI's price/earnings ratio is 114.94% lower, now standing at -3.6.
  • Over the past 243 months, SPPI's price/sales ratio has gone up 4.4.

Below are key valuation metrics over time for SPPI.

Stock Date P/S P/B P/E EV/EBIT
SPPI 2023-05-23 9.0 8.7 -3.6 -3.3
SPPI 2023-05-22 9.5 9.2 -3.8 -3.5
SPPI 2023-05-19 9.9 9.5 -3.9 -3.7
SPPI 2023-05-18 9.7 9.3 -3.8 -3.6
SPPI 2023-05-17 9.7 9.3 -3.9 -3.6
SPPI 2023-05-16 9.4 9.0 -3.7 -3.5

SPPI Growth Metrics

    The 4 year net cashflow from operations growth rate now stands at -139.09%.
  • Its 4 year price growth rate is now at -55.54%.
  • Its 2 year net cashflow from operations growth rate is now at 9.87%.
SPPI's revenue has moved down $0 over the prior 15 months.

The table below shows SPPI's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 0 -101.998 -106.13
2022-06-30 0 -109.087 -117.289
2022-03-31 0 -115.291 -138.373
2021-12-31 0 -119.486 -158.628
2021-09-30 0 -122.442 -158.672
2021-06-30 0 -125.378 -174.04

SPPI's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • SPPI has a Quality Grade of D, ranking ahead of 20.75% of graded US stocks.
  • SPPI's asset turnover comes in at 0 -- ranking 440th of 682 Pharmaceutical Products stocks.
  • PAHC, HSKA, and FLXN are the stocks whose asset turnover ratios are most correlated with SPPI.

The table below shows SPPI's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0 NA -2.646
2021-03-31 0 NA -1.994
2020-12-31 0 NA -1.877
2020-09-30 0 NA -1.683
2020-06-30 0 NA -1.386
2020-03-31 0 NA -1.103

SPPI Price Target

For more insight on analysts targets of SPPI, see our SPPI price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $6.20 Average Broker Recommendation 1.58 (Moderate Buy)

Spectrum Pharmaceuticals, Inc. (SPPI) Company Bio

Spectrum Pharmaceuticals is a leading biotechnology company focused on acquiring, developing, and commercializing drug products, with a primary focus in hematology and oncology. The company was founded in 1987 and is based in Henderson, Nevada.

SPPI Latest News Stream

Event/Time News Detail
Loading, please wait...

SPPI Latest Social Stream

Loading social stream, please wait...

View Full SPPI Social Stream

Latest SPPI News From Around the Web

Below are the latest news stories about SPECTRUM PHARMACEUTICALS INC that investors may wish to consider to help them evaluate SPPI as an investment opportunity.

Spectrum Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

BOSTON, May 17, 2023--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) ("Spectrum" or the "Company"), a biopharmaceutical Company focused on novel and targeted oncology announced today that on May 16, 2023, the Company received a written notification from the Listing Qualifications Staff (the "Staff") of the Nasdaq Stock Market LLC (Nasdaq) that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2).

Yahoo | May 17, 2023

News Flash: Analysts Just Made A Captivating Upgrade To Their Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Forecasts

Spectrum Pharmaceuticals, Inc. ( NASDAQ:SPPI ) shareholders will have a reason to smile today, with the analysts making...

Yahoo | May 14, 2023

Q1 2023 Assertio Holdings Inc Earnings Call

Q1 2023 Assertio Holdings Inc Earnings Call

Yahoo | May 10, 2023

Spectrum Pharmaceuticals (SPPI) Reports Q1 Loss, Tops Revenue Estimates

Spectrum Pharma (SPPI) delivered earnings and revenue surprises of 60% and 27.99%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | May 9, 2023

Spectrum Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Update

BOSTON, May 09, 2023--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a commercial stage biopharmaceutical company focused on novel and targeted oncology therapies, announced today financial results for the three-month period ended March 31, 2023, and provided a corporate update.

Yahoo | May 9, 2023

Read More 'SPPI' Stories Here

SPPI Price Returns

1-mo 4.90%
3-mo 7.00%
6-mo 127.66%
1-year 52.86%
3-year -64.69%
5-year -94.57%
YTD 190.37%
2022 -70.98%
2021 -62.76%
2020 -6.32%
2019 -58.40%
2018 -53.83%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!